The present disclosure relates to antibodies having specificity to myosin 18A and uses thereof. In particular, the present disclosure relates to an antibody having specificity to myosin 18A comprising a heavy chain comprising i) a H-CDR1 having at least 90% of identity with the H-CDR1 of DY12, ii) a H-CDR2 having at least 90% of identity with the H-CDR2 of DY12 and iii) a H-CDR3 having at least 90% of identity with the H-CDR3 of DY12 and a light chain comprising i) a L-CDR1 having at least 90% of identity with the L-CDR1 of DY12, ii) a L-CDR2 having at least 90% of identity with the L-CDR2 of DY12 and iii) a L-CDR3 having at least 90% of identity with the L-CDR3 of DY12.
